Does Rallies show 13F holders for VSTM?

Yes. Rallies tracks hedge fund and 13F ownership data for VSTM, including fund names, share counts, latest tracked quarter, and position changes when available.

Is VSTM research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VSTM. It does not provide personalized investment advice.

VSTM (Verastem, Inc.) Stock Analysis - Hedge Fund Holdings

Verastem, Inc. (VSTM) is a publicly traded Healthcare sector company. As of May 21, 2026, VSTM trades at $4.22 with a market cap of $374.34M and a P/E ratio of -1.73. VSTM moved -0.72% today. Year to date, VSTM is -39.88%; over the trailing twelve months it is -48.57%. Its 52-week range spans $2.54 to $11.25. Analyst consensus is strong buy with an average price target of $16.00. Rallies surfaces VSTM's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns VSTM stock?

Hedge funds tracked by Rallies that own VSTM include Viking Global, Farallon Capital, Orbimed Advisors, and Panagora Asset. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Verastem, Inc..

VSTM Key Metrics

Key financial metrics for VSTM
Metric	Value
Price	$4.22
Market Cap	$374.34M
P/E Ratio	-1.73
EPS	$-2.40
Dividend Yield	0.00%
52-Week High	$11.25
52-Week Low	$2.54
Volume	2.58K
Avg Volume	0
Revenue (TTM)	$49.59M
Net Income	$-193.96M
Gross Margin	0.00%

Top Hedge Funds Holding VSTM

Viking Global holds 2.46M shares of VSTM, changed +0.00% as of Mar 31, 2024.
Farallon Capital holds 2.00M shares of VSTM, changed +0.00% as of Dec 31, 2025.
Orbimed Advisors holds 887.56K shares of VSTM, changed -68.99% as of Sep 30, 2025.
Panagora Asset holds 244.10K shares of VSTM, changed +0.01% as of Mar 31, 2026.

Latest VSTM News

Verastem Updates Q1 Results, Highlights Phase II/III Oncology Pipeline Progress — May 7, 2026
Verastem Hits $30.9M Launch Revenue with 300 Prescribers, Shows Cash Runway into H1 2027 — Mar 5, 2026
Verastem Reports $0.50 Q4 Loss, Revenue Climbs to $17.5M — Mar 4, 2026
Verastem Oncology Shuts Down KRAS G12C RAMP-203 Trial, 69% Response in KRAS G12D Study — Dec 30, 2025

Recent VSTM Insider Trades

Paterson Dan sold 806 (~$4.69K) on May 4, 2026.
Paterson Dan sold 970 (~$6.49K) on Feb 4, 2026.
Paterson Dan sold 10.32K (~$73.90K) on Jan 12, 2026.

VSTM Analyst Consensus

7 analysts cover VSTM: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $16.00.

Common questions about VSTM

Who owns VSTM stock?: Hedge funds tracked by Rallies that own VSTM include Viking Global, Farallon Capital, Orbimed Advisors, and Panagora Asset. The latest tracked quarter is Mar 31, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Verastem, Inc..
Does Rallies show 13F holders for VSTM?: Yes. Rallies tracks hedge fund and 13F ownership data for VSTM, including fund names, share counts, latest tracked quarter, and position changes when available.
Is VSTM research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VSTM. It does not provide personalized investment advice.